Development of MPO-ANCA-related Vasculitis in Systemic Sclerosis: Report of Two Cases and Review of the Literature

  • Makinodan Eri
    Department of Dermatology, Nara Medical University School of Medicine
  • Kobayashi Nobuhiko
    Department of Dermatology, Nara Medical University School of Medicine
  • Hoshino Sachiko
    Department of Dermatology, Nara Medical University School of Medicine
  • Izumi Atsuko
    Department of Dermatology, Nara Medical University School of Medicine
  • Yokoi Shoko
    Department of Dermatology, Nara Medical University School of Medicine
  • Yamamoto Yoshiteru
    Department of Dermatology, Nara Medical University School of Medicine
  • Asada Hideo
    Department of Dermatology, Nara Medical University School of Medicine
  • Asai Osamu
    First Department of Internal Medicine, Nara Medical University School of Medicine
  • Nakatani Kimihiko
    First Department of Internal Medicine, Nara Medical University School of Medicine
  • Kumamoto Makiko
    Second Department of Internal Medicine, Nara Medical University School of Medicine
  • Suzaki Yasue
    Second Department of Internal Medicine, Nara Medical University School of Medicine
  • Hamada Kaoru
    Second Department of Internal Medicine, Nara Medical University School of Medicine
  • Miyagawa Sachiko
    Department of Dermatology, Nara Medical University School of Medicine

Bibliographic Information

Other Title
  • MPO-ANCA関連血管炎と全身性強皮症:半月体形成性糸球体腎炎,多発単神経炎を合併した全身性強皮症の2例の検討と文献的考察
  • MPO ANCA カンレン ケッカンエン ト ゼンシンセイ キョウヒショウ ハンゲツタイ ケイセイセイ シキュウタイジンエン タハツタンシンケイエン オ ガッペイ シタ ゼンシンセイ キョウヒショウ ノ 2レイ ノ ケントウ ト ブンケンテキ コウサツ

Search this article

Description

We report two patients, a 59-year-old female and a 21-year-old female with systemic sclerosis (SSc) who demonstrated myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA). Both patients developed crescentic glomerulonephritis and mononeuritis multiplex, respectively, nine years after the onset of SSc. We diagnosed these patients as having an overlap of SSc and MPO-ANCA-related vasculitis. A combination of oral administration of prednisolone and intravenous cyclophosphamide improved their vasculitic symptoms. We determined the incidence of ANCA-related vasculitis in SSc patients at our hospital. Of the 21 SSc patients examined, only the two patients described here were MPO-ANCA positive. A literature review demonstrated that the features of Japanease SSc patients who produce MPO-ANCA included a high incidence of positive anti-topoisomerase I antibody (71%) and a long lag phase between the onset of SSc and the development of MPO-ANCA (average 10 years, 0.5~30 years). Although the development of MPO-ANCA-related vasculitis is extremely rare in SSc patients, it is clinically of great importance. Acute progressive glomerulonephritis as well as pulmonary hemorrhage caused by ANCA-related vasculitis can determine the prognosis of such patients. If clinically evident vasculitis occurs in an SSc patient, particularly a patient with positive anti-topoisomerase I antibody and a long lag phase from the onset of SSc, prompt diagnosis of ANCA-related vasculitis and the early initiation of immunosuppressive therapy, particularly in the case of life-threatening conditions, can be determinative factors for a good outcome.

Journal

Citations (2)*help

See more

References(36)*help

See more

Details 詳細情報について

Report a problem

Back to top